IP Library › Granted Patent US 8,491,878
Granted Patent B2
US 8,491,878 · App. 12/353,280 · Granted Jul 23, 2013

Sanitizing formulation

Inventors: Simon King (Weybridge, GB); Madhu Parmar (Weybridge, GB); Kimberly Biedermann (Parsippany, NJ); Philip Oths (Parsippany, NJ)
Assignee: Glaxo Group Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,491,878
App. No.
12/353,280
Granted
Jul 23, 2013
Kind
B2
Abstract

A sanitizing formulation comprising a solution of an acidic polymer and an anionic surfactant in a liquid vehicle. Suitable acidic polymers are those which include adjacent —[—CR 1 .COOH—]— units where R 1 is defined in their structure, for example polymers based on maleic acid moieties which typically include —[—CH.COOH—CH.COOH—]— units, such as known Gantrez™ polymers. A suitable anionic surfact is sodium lauryl sulphate.

Claims (10)

1. An alcohol-free sanitizing formulation having anti-viral activity comprising a solution of 1-5 wt % of an acidic polymer comprising a homopolymer of acrylic acid crosslinked with an allyl ether, 1-5 wt % of an anionic surfactant, and 0.5-7 wt % of citric acid made up to 100% with water, at pH 2-4, wherein the acidic polymer and anionic surfactant interact to form a viscous gel.

2. The sanitizing formulation according to claim 1 wherein the acidic polymer comprises a homopolymer of acrylic acid crosslinked with an allyl ether of pentaerythritol, of sucrose or of propylene.

3. The sanitizing formulation according to claim 2 wherein the acidic polymer comprises Carbopol ETD 2020.

4. The sanitizing formulation according to claim 1 wherein the anionic surfactant is a compound having a hydrophilic anionic group and an associated cation.

5. The sanitizing formulation according to claim 4 wherein the anionic surfactant is selected from sodium lauryl sulphate, sodium laureth sulphate, and alpha-olefin sulphates.

6. The sanitizing formulation according to claim 5 comprising Carbopol™ ETD 2020 and sodium lauryl sulphate or an alpha-olefin sulphate.

7. The sanitizing formulation according to claim 1 wherein the acidic polymer and the anionic surfactant are present together in the solution in the ratio of weight % acidic polymer:anionic surfactant 1-2:2-1.

8. The sanitizing formulation according to claim 1 provided for use as a sanitizing formulation for a surface.

9. A concentrate suitable for dilution with a liquid vehicle to thereby provide a sanitizing formulation as claimed in claim 1 .

10. A sanitising formulation according to claim 1 having anti-viral activity consisting of a solution of 1-5 wt % of an acidic polymer comprising a homopolymer of acrylic acid crosslinked with an allyl ether, 1-5 wt % of an anionic surfactant, and 0.5-7 wt % of citric acid made up to 100% with water, at pH 2-4, wherein the acidic polymer and the anionic surfactant interact to form a viscous gel.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2009
From: BIEDERMAN, KIMBERLY; OTHS, PHILIP; KING, SIMON; PARMAR, MADHU
To: GLAXO GROUP LIMITED
Reel/Frame 022632/0328 →
Priority Claims (1)
GB 0800788.2 · Jan 16, 2008 · national
Continuity (1)
Related Publication 20090208444A1 · Aug 20, 2009